Of a total of 99 COVID-19 patients, 6% had increased activated partial thromboplastin time, 5% elevated prothrombin and 36% elevated D-dimer (a protein fragment resulting from clot dissolution) levels. This evidence concerns the gene F2 and COVID-19.